Where are all the AV fistulas?

Area of Science:

• Nephrology
• Vascular Surgery
• Health Services Research

Background:

• Despite consensus on the importance of arteriovenous (AV) fistulas for dialysis access, U.S. prevalence remains low.
• Current AV fistula rates in incident and prevalent patients fall short of targets seen in focused programs and Europe.
• The Dialysis Outcomes Quality Initiative (DOQI) guidelines published in 1997 have not significantly increased AV fistula prevalence.

Discussion:

• Systemic barriers impede AV fistula placement, including inadequate pre-end-stage renal disease (ESRD) care and preoperative imaging funding.
• Financial disincentives, lack of accountability, and educational gaps contribute to the slow progress in increasing AV fistula rates.
• Existing clinical practice guidelines (DOQI/K/DOQI) are insufficient without addressing broader systemic issues impacting care delivery.

Key Insights:

• Modest increases in AV fistula prevalence since 1997 highlight persistent challenges in the U.S. dialysis community.
• Comparison with European countries and focused U.S. programs reveals significant room for improvement in AV fistula utilization.
• Addressing systemic issues is paramount for achieving higher AV fistula rates and improving dialysis outcomes.

Outlook:

• Future improvements in AV fistula prevalence necessitate a comprehensive approach to overcome identified systemic barriers.
• Modifying healthcare structures beyond clinical guidelines is essential for effective implementation of AV fistula initiatives.
• A realistic appraisal and correction of system-level problems are required to enhance AV fistula placement rates.